글로벌 라임병 약물 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 라임병 약물 시장

라임병 유병률 증가와 새로운 치료법에 대한 수요 증가는 라임병 시장 가치의 성장에 기인합니다. Data Bridge Market Research는 라임병이 2021-2028년 예측 기간 동안 약 6.4%의 CAGR을 보일 것이라고 분석합니다.

라임병은 보렐리아 부르그도르페리라는 박테리아 에 의해 발생하는 진드기 매개 질병입니다 . 라임병은 감염된 검은 다리 진드기에 물려 사람에게 전염됩니다. 감염은 혈류를 통해 퍼져 단계에 따라 광범위한 증상을 유발합니다. 라임병은 발적, 피로, 피부 발진 및 기타 독감과 유사한 증상과 같은 일반적인 징후나 증상을 보이는 전염성 질병입니다.

라임병의 유병률 증가는 시장 성장에 영향을 미치는 주요 요인입니다. 진드기 매개 질병과 벡터 매개 질병의 수의 증가는 라임병 시장 가치의 성장을 촉진하고 있습니다. 국내 애완동물 애호가의 확산은 간접적으로 라임병 시장 성장을 유도하고 있습니다.

그러나 저개발 경제권에서 질병에 대한 인식 부족은 시장 성장률을 탈선시킬 것입니다. 이 지역의 저개발 의료 인프라는 시장 성장률을 저하시키는 또 다른 요인입니다. 치료와 관련된 높은 비용은 성장 범위를 더욱 제한할 것입니다.

This lyme disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lyme disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lyme Disease Market Scope and Market Size

The lyme disease market is segmented on the basis of disease type, stages type, treatment type, diagnosis type, drug type, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on the disease type, the lyme disease market has been segmented into lyme carditis, lyme arthritis, neurologic lyme disease, borrelial lymphocytosis and post-treatment lyme disease syndrome.
• On the basis of stages type, the lyme disease market is segmented into localized early stage, disseminated stage and late stage.
• On the basis of treatment type, the market is segmented into medication and tick removal.
• On the basis of diagnosis type, the market is segmented into blood test, serological test, urine antigen tests, lymphocytic transformation test, immuno fluorescent staining, nucleic acid test and enzyme-linked immuno sorbent assay (ELISA) Test.
• On the basis of drug type, the market is segmented into doxycycline, cefuroxime axetil, amoxicillin, ceftriaxone and others.
• On the basis of route of administration, the lyme disease market is segmented into oral, tropical and intravenous.
• On the basis of end users, the lyme disease market is segmented into hospitals, homecare, specialty clinics and others.

Lyme Disease Market Country Level Analysis

The lyme disease market is analysed and market size insights and trends are provided by country, disease type, stages type, treatment type, diagnosis type, drug type, route of administration and end users as referenced above.

The countries covered in the lyme disease market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the lyme disease market owing to the prevalence of sophisticated healthcare infrastructure, increased research and development proficiencies by the pharmaceutical companies and rapid adoption of new and better healthcare technologies. Rising prevalence of lyme disease is inducing the dominance of the region as well. Asia-Pacific on the other hand is projected to score highest growth rate for the forecast period owing to rising expenditure to develop healthcare infrastructure, rising domestic pet lovers and rising awareness about the illness.

The country section of the lyme disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Lyme disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of lyme disease market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Lyme Disease Market Share Analysis

The lyme disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lyme disease market.

라임병 시장 보고서에 포함된 주요 기업으로는 Mylan NV, GlaxoSmithKline plc., Pfizer Inc., Abbott, Eli Lilly And Company., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Sanofi, Novartis AG, AstraZeneca, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Valneva SE., Bio-Rad Laboratories, Inc., T2 Biosystems, Inc., Canon USA, Inc., G&W Laboratories, Inc., BioDiem 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-37315